HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
31.38 USD
+0.15 (+0.48%)
31.59 USD
+0.21 (+0.67%)
We assign a fundamental rating of 5 out of 10 to HIMS. HIMS was compared to 102 industry peers in the Health Care Providers & Services industry. HIMS has only an average score on both its financial health and profitability. HIMS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
- HIMS had positive earnings in the past year.
- HIMS had a positive operating cash flow in the past year.
- In the past 5 years HIMS reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
- The Return On Assets of HIMS (5.99%) is better than 83.33% of its industry peers.
- With an excellent Return On Equity value of 23.03%, HIMS belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
- With a decent Return On Invested Capital value of 5.84%, HIMS is doing good in the industry, outperforming 60.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HIMS has a Profit Margin of 6.05%. This is amongst the best in the industry. HIMS outperforms 82.35% of its industry peers.
- Looking at the Operating Margin, with a value of 5.96%, HIMS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
- HIMS has a better Gross Margin (75.01%) than 90.20% of its industry peers.
- HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
- HIMS has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, HIMS has more shares outstanding
- There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- HIMS has an Altman-Z score of 3.91. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of HIMS (3.91) is better than 75.49% of its industry peers.
- The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
- HIMS has a Debt to FCF ratio (8.13) which is comparable to the rest of the industry.
- HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of HIMS (1.67) is worse than 68.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 3.91 |
ROIC/WACC0.65
WACC8.92%
2.3 Liquidity
- HIMS has a Current Ratio of 1.88. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- HIMS has a better Current ratio (1.88) than 77.45% of its industry peers.
- HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
- HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
- The Revenue has grown by 78.02% in the past year. This is a very strong growth!
- Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
- HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.57% yearly.
- The Revenue is expected to grow by 22.77% on average over the next years. This is a very strong growth
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y28.57%
Revenue Next Year60.27%
Revenue Next 2Y37.54%
Revenue Next 3Y31.01%
Revenue Next 5Y22.77%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 58.11, the valuation of HIMS can be described as expensive.
- The rest of the industry has a similar Price/Earnings ratio as HIMS.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, HIMS is valued quite expensively.
- HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 52.37.
- HIMS's Price/Forward Earnings is on the same level as the industry average.
- HIMS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.11 | ||
| Fwd PE | 52.37 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS is on the same level as its industry peers.
- HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.79 | ||
| EV/EBITDA | 41.32 |
4.3 Compensation for Growth
- HIMS has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as HIMS's earnings are expected to grow with 13.84% in the coming years.
PEG (NY)N/A
PEG (5Y)0.96
EPS Next 2Y5.34%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
- No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
31.38
+0.15 (+0.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners94.2%
Inst Owner Change0.05%
Ins Owners5.93%
Ins Owner Change-3.07%
Market Cap7.14B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target44.47 (41.71%)
Short Float %31.63%
Short Ratio3.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-6.45%
PT rev (3m)-10.71%
EPS NQ rev (1m)17.42%
EPS NQ rev (3m)-78.62%
EPS NY rev (1m)-3.6%
EPS NY rev (3m)-23.52%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-1.48%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.11 | ||
| Fwd PE | 52.37 | ||
| P/S | 3.23 | ||
| P/FCF | 59.79 | ||
| P/OCF | 21.98 | ||
| P/B | 12.3 | ||
| P/tB | 56.33 | ||
| EV/EBITDA | 41.32 |
EPS(TTM)0.54
EY1.72%
EPS(NY)0.6
Fwd EY1.91%
FCF(TTM)0.52
FCFY1.67%
OCF(TTM)1.43
OCFY4.55%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)0.96
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 3.91 |
F-Score3
WACC8.92%
ROIC/WACC0.65
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-12.6%
EPS Next 2Y5.34%
EPS Next 3Y13.84%
EPS Next 5Y28.57%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.27%
Revenue Next 2Y37.54%
Revenue Next 3Y31.01%
Revenue Next 5Y22.77%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.26%
EBIT Next 3Y90.18%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 4 / 10.